足部中膜动脉钙化影响慢性肢体威胁性缺血孤立踝下干预的结局
该回顾性研究分析了2007至2022年间223例因组织缺损接受孤立踝下(足背动脉及内、外侧跗动脉)腔内干预的慢性肢体威胁性缺血患者,所有患者均有糖尿病。足部X线盲法评估足部中膜动脉钙化(pMAC)并0-5评分,按患者进行意向性治疗分析,评估无截肢生存率。结果显示pMAC严重程度与无截肢生存率下降相关,严重pMAC与截肢相关,应作为医患共同决策的变量。
要点
- 孤立踝下干预后5年总体无截肢生存率为35%±9%。
- pMAC严重程度与无截肢生存率降低相关。
- 严重pMAC与截肢相关,应考虑作为医患共同决策的变量。
核心结论
- pMAC严重程度增加影响糖尿病患者踝下干预的技术和长期结局。
- 严重pMAC与截肢相关,应作为糖尿病慢性肢体威胁性缺血患者医患共同决策的变量。
研究设计与样本
- 回顾性查询2007至2022年因组织缺损行下肢腔内干预的数据库,选取慢性肢体威胁性缺血且接受足背动脉及内、外侧跗动脉孤立踝下干预并有足部X线的患者。
- 足部X线盲法评估pMAC并按0至5分评分,排除合并股浅动脉和胫动脉干预者,按患者进行意向性治疗分析,评估无截肢生存率。
- 共纳入223例患者(女性51%,西班牙裔87%,平均年龄66岁,323条血管)。
主要发现
- 所有患者均有糖尿病,96%有高血压,79%有高脂血症,63%有慢性肾功能不全(其中55%接受血液透析)。
- 大多数患者为WIfI 3期,pMAC严重(评分=5)占48%,中度(评分=2-4)占31%,轻度(评分=0-1)占21%。
- 技术成功率为94%,每例患者中位治疗1条血管,所有失败均发生在严重pMAC。
- 术后90天主要不良心血管事件为0.9%,WIfI缺血分级改善51%,3个月伤口愈合率为69%,未愈合者接受膝下截肢。
- 总体5年无截肢生存率为35%±9%,pMAC严重程度与无截肢生存率降低相关。
临床怎么用
- 作者认为严重pMAC与截肢相关,应作为糖尿病慢性肢体威胁性缺血患者医患共同决策的变量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inframalleolar disease is present in most diabetic patients presenting with tissue loss. Inframalleolar (pedal) artery disease and pedal medial arterial calcification (pMAC) are associated with major amputation in patients with chronic limb-threatening ischemia (CLTI). This study aimed to examine the impact of pMAC on the outcomes after isolated inframalleolar (pedal artery) interventions. METHODS: A database of lower extremity endovascular intervention for patients with tissue loss between 2007 and 2022 was retrospectively queried. Patients with CLTI were selected, and those undergoing isolated inframalleolar intervention on the dorsalis pedis and medial and lateral tarsal arteries and who had foot x-rays were identified. X-rays were assessed blindly for pMAC and scored on a scale of 0 to 5. Patients with concomitant superficial femoral artery and tibial interventions were excluded. Intention to treat analysis by the patient was performed. Amputation-free survival (survival without major amputation) was evaluated. RESULTS: A total of 223 patients (51% female; 87% Hispanic; average age, 66 years; 323 vessels) underwent isolated infra-malleolar intervention for tissue loss. All patients had diabetes, 96% had hypertension, 79% had hyperlipidemia, and 63% had chronic renal insufficiency (55% of these were on hemodialysis). Most of the patients had Wound, Ischemia, and foot Infection (WIfI) stage 3 disease and had various stages of pMAC: severe (score = 5) in 48%, moderate (score = 2-4) in 31%, and mild (score = 0-1) in 21% of the patients. Technical success was 94%, with a median of one vessel treated per patient. All failures were in severe pMAC. Overall, major adverse cardiovascular events was 0.9% at 90 days after the procedure. Following the intervention, most patients underwent a planned forefoot amputation (single digit, multiple digits, ray amputation, or trans-metatarsal amputation). WIfI ischemic grade was improved by 51%. Wound healing at 3 months was 69%. Those not healing underwent below-knee amputations. The overall 5-year amputation-free survival rate was 35% ± 9%. The severity of pMAC was associated with decreased AFS. CONCLUSIONS: Increasing severity of pMAC influences the technical and long-term outcomes of infra-malleolar intervention in diabetes. Severe pMAC is associated with amputation and should be considered as a variable in the shared decision-making of diabetic patients with CLTI.
引用
- Cheun TJ, Hart JP, Davies MG, et al. Pedal medial arterial calcification influences the outcomes of isolated infra-malleolar interventions for chronic limb-threatening ischemia. J Vasc Surg. 2024. PMID: 38649103. doi:10.1016/j.jvs.2024.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。